The authors revealed that purinergic signaling in gliomas was shaped by genotype, lineage, and functional state, and that core enzymes expressed by tumor and myeloid cells were organized to promote adenosine-rich microenvironments potentially amenable to therapeutic targeting.
[Nature Communications]
